Helmholtz Gemeinschaft


Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: Article | Review | Editorial


A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Habringer, S. and Demel, U.M. and Fietz, A.K. and Lammer, F. and Schroers, R. and Hofer, S. and Bairey, O. and Braess, J. and Meier-Stiegen, A.S. and Stuhlmann, R. and Schmidt-Hieber, M. and Hoffmann, J. and Zinngrebe, B. and Kaiser, U. and Reimer, P. and Möhle, R. and Fix, P. and Höffkes, H.G. and Langenkamp, U. and Büschenfelde, C.M.Z. and Hopfer, O. and Stoltefuß, A. and La Rosée, P. and Blasberg, H. and Jordan, K. and Kaun, S. and Meurer, A. and Unteroberdörster, M. and von Brünneck, A.C. and Capper, D. and Heppner, F.L. and Chapuy, B. and Janz, M. and Schwartz, S. and Konietschke, F. and Vajkoczy, P. and Korfel, A. and Keller, U.
European Journal of Cancer 196 : 113436. January 2024

TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg, S. and Dernbach, G. and Dragomir, M.P. and Schlachtenberger, G. and Boschung, K. and Friedrich, C. and Standvoss, K. and Ruff, L. and Anders, P. and Grohé, C. and Randerath, W. and Merkelbach-Bruse, S. and Quaas, A. and Heldwein, M. and Keilholz, U. and Hekmat, J.K. and Rückert, C. and Büttner, R. and Horst, D. and Klauschen, F. and Frost, N.
European Journal of Cancer 197 : 113474. January 2024

Tumour mutational burden and survival with molecularly matched therapy.
de Bortoli, T. and Benary, M. and Horak, P. and Lamping, M. and Stintzing, S. and Tinhofer, I. and Leyvraz, S. and Schäfer, R. and Klauschen, F. and Keller, U. and Stenzinger, A. and Fröhling, S. and Kurzrock, R. and Keilholz, U. and Rieke, D.T. and Jelas, I.
European Journal of Cancer 190 : 112925. September 2023

Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial.
Peuker, C.A. and Yaghobramzi, S. and Grunert, C. and Keilholz, L and Gjerga, E. and Hennig, S. and Schaper, S. and Na, I.K. and Keller, U. and Brucker, S. and Decker, T. and Fasching, P. and Fehm, T. and Janni, W. and Kümmel, S. and Schneeweiss, A. and Schuler, M. and Lüftner, D. and Busse, A.
European Journal of Cancer 162 : 45-55. February 2022

Support of a molecular tumour board by an evidence-based decision management system for precision oncology.
Lamping, M. and Benary, M. and Leyvraz, S. and Messerschmidt, C. and Blanc, E. and Kessler, T. and Schütte, M. and Lenze, D. and Jöhrens, K. and Burock, S. and Klinghammer, K. and Ochsenreither, S. and Sers, C. and Schäfer, R. and Tinhofer, I. and Beule, D. and Klauschen, F. and Yaspo, M.L. and Keilholz, U. and Rieke, D.T.
European Journal of Cancer 127 : 41-51. March 2020

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis, E. and Julie, C. and Emile, J.F. and Mauer, M. and Nordlinger, B. and Aust, D. and Roth, A. and Lutz, M.P. and Gruenberger, T. and Wrba, F. and Sorbye, H. and Bechstein, W. and Schlag, P. and Fisseler, A. and Ruers, T.
European Journal of Cancer 51 (17): 2708-2717. November 2015

Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer.
Jehn, C.F. and Böning, L. and Kröning, H. and Pezzutto, A. and Lüftner, D.
European Journal of Cancer 50 (7): 1269-1275. May 2014

Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
Aleksandrova, K. and Pischon, T. and Buijsse, B. and May, A.M. and Peeters, P.H. and Bueno-de-Mesquita, H.B. and Jenab, M. and Fedirko, V. and Dahm, C.C. and Siersema, P.D. and Freisling, H. and Ferrari, P. and Overvad, K. and Tjønneland, A. and Trichopoulou, A. and Lagiou, P. and Naska, A. and Pala, V. and Mattiello, A. and Ohlsson, B. and Jirström, K. and Key, T.J. and Khaw, K.T. and Riboli, E. and Boeing, H.
European Journal of Cancer 49 (16): 3526-3536. November 2013

Comparative evaluation of the biological properties of reducible and acid-sensitive folate prodrugs of a highly potent doxorubicin derivative.
Abu Ajaj, K. and El-Abadla, N. and Welker, P. and Azab, S. and Zeisig, R. and Fichtner, I. and Kratz, F.
European Journal of Cancer 48 (13): 2054-2065. September 2012

The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department - A randomised controlled study.
Goerling, U. and Foerg, A. and Sander, S. and Schramm, N. and Schlag, P.M.
European Journal of Cancer 47 (13): 2009-2014. September 2011

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group.
Pelzer, U. and Schwaner, I. and Stieler, J. and Adler, M. and Seraphin, J. and Doerken, B. and Riess, H. and Oettle, H.
European Journal of Cancer 47 (11): 1676-1681. July 2011

In vivo models for endocrine-dependent breast carcinomas: special considerations of clinical relevance.
Fichtner, I. and Becker, M. and Zeisig, R. and Sommer, A.
European Journal of Cancer 40 (6): 845-851. April 2004

Detection of cell-free nucleic acids in bronchial lavage fluid supernatants from patients with lung cancer.
Schmidt, B. and Carstensen, T. and Engel, E. and Jandrig, B. and Witt, C. and Fleischhacker, M.
European Journal of Cancer 40 (3): 452-460. February 2004

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas.
Fichtner, I. and Slisow, W. and Gill, J. and Becker, M. and Elbe, B. and Hillebrand, T. and Bibby, M.
European Journal of Cancer 40 (2): 298-307. January 2004

Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period.
Maschmeyer, G. and Bertschat, F.L. and Moesta, K.T. and Haeusler, E. and Held, T.K. and Nolte, M. and Osterziel, K.J. and Papstein, V. and Peters, M. and Reich, G. and Schmutzler, M. and Sezer, O. and Stula, M. and Wauer, H. and Woertz, T. and Wischnewsky, M. and Hohenberger, P.
European Journal of Cancer 39 : 783-792. 1 April 2003

Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).
Fichtner, I. and Becker, M. and Baumgart, J.
European Journal of Cancer 39 (6): 801-807. April 2003

The EORTC laboratory research division.
Brunner, N. and Double, J. and Fichtner, I. and Gescher, A. and Newell, D. and Oosterhuis, W. and Price, P.
European Journal of Cancer 38 (4): S14-S18. March 2002

Colorectal cancer - what is standard surgery?
Hohenberger, P.
European Journal of Cancer 37 (S7) : 173-187. 1 January 2001

Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters.
Seitz, S. and Werner, S. and Fischer, J. and Nothnagel, A. and Schlag, P.M. and Scherneck, S.
European Journal of Cancer 36 (12): 1507-1513. 1 August 2000

Brain metastases in breast cancer: prognostic factors and management.
Lentzsch, S. and Reichardt, P. and Weber, F. and Budach, V. and Doerken, B.
European Journal of Cancer 35 : 580-585. 1 April 1999

Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer.
Decker-Baumann, C. and Buhl, K. and Frohmueller, S. and von Herbay, A. and Dueck, M. and Schlag, P.M.
European Journal of Cancer 35 : 202-207. 1 February 1999

Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt, C.A. and Schwaeble, W. and Wittig, B.M. and Meyer Zum Bueschenfelde, K.H. and Dippold, W.G.
European Journal of Cancer 35 : 117-124. 1 January 1999

Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: Implications for cell adhesion and signaling.
Ghadimi, B.M. and Behrens, J. and Hoffmann, I. and Haensch, W. and Birchmeier, W. and Schlag, P.M.
European Journal of Cancer 35 (1): 60-65. January 1999

Increased autologous blood donation in rectal cancer by recombinant human erythropoietin (rhEPO).
Rau, B. and Schlag, P.M. and Willeke, F. and Herfarth, C. and Stephan, P. and Franke, W.
European Journal of Cancer 34 : 992-998. 1 June 1998

Rhabdomyolysis and renal function impairment after isolated limb perfusion-comparison between the effects of perfusion with rhTNFalpha 'Triple-drug' regimen.
Hohenberger, P. and Haier, J. and Schlag, P.M.
European Journal of Cancer 33 : 596-601. 1 January 1997

Modulation of 5-fluorouracil with methotrexate and low-dose N- (phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. results of a phase II study.
Koehne, C.H. and Harstrick, A. and Hiddemann, W. and Schoeffski, P. and Wilke, H. and Bokemeyer, C. and Doerken, B. and Schmoll, H.J.
European Journal of Cancer 33 : 1896-1899. 1 January 1997

Is isolated limb perfusion of metastatic malignant melanoma of the extremity worthwhile?
Koops, H.S. and Garbe, C. and Hohenberger, P.
European Journal of Cancer 32A : 1633-1640. 1 September 1996

MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas.
Stein, U. and Shoemaker, R.H. and Schlag, P.M.
European Journal of Cancer 32 A : 86-92. 1 January 1996

European school of oncology position paper - gene therapy for the medical oncologist.
Blaese, M. and Blankenstein, T. and Brenner, M. and Cohenhaguenauer, O. and Gansbacher, B. and Sorrentino, B. and Velu, T.
European Journal of Cancer 31A (9): 1531-1537. 1 January 1995

A pilot study of a new therapeutic approach in the treatment of locally advanced stages of rectal cancer - neoadjuvant radiation, chemotherapy and regional hyperthermia.
Riess, H. and Loeffel, J. and Wust, P. and Rau, B. and Gremmler, M. and Speidel, A. and Schlag, P.M.
European Journal of Cancer 31A : 1356-1360. 1 January 1995

Increasing tumour immunogenicity by genetic modification.
Blankenstein, T.
European Journal of Cancer 30A : 1182-1187. 1 January 1994

Serum erythropoietin levels in patients with solid tumours.
Kettelhack, C. and Schoeter, D. and Matthias, D. and Schlag, P.M.
European Journal of Cancer 30A : 1289-1291. 1 January 1994

Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevated drugs.
Stein, U. and Walther, W. and Wunderlich, V.
European Journal of Cancer 30A (10): 1541-1545. 1994

Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H215O and [18F]uracil positron emission tomography (PET).
Hohenberger, P. and Strauss, L.G. and Lehner, B. and Frohmueller, S. and Dimitrakopoulou, A. and Schlag, P.M.
European Journal of Cancer 29A : 1682-1686. 1 January 1993

Properties of two epithelial cell lines derived from HPV-associated cervical and vulvar lesions.
Kiessling, U. and Kube, D. and Janda, J. and Bergmann, S. and Johannsmeyer, K.D. and Hauff, P. and Arnold, W. and Waehlte, H.
European Journal of Cancer 29A : 1746-1753. 1 January 1993

Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients.
Stein, U. and Wunderlich, V. and Haensch, W. and Schmidt-Peter, P.
European Journal of Cancer 29A (14): 1979-1981. 1993

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin.
Donnelly, J.P. and Maschmeyer, G. and Daenen, S.
European Journal of Cancer 28A : 873-878. 1 January 1992


Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson, A.D.J. and Federico, S. and Gatz, S.A. and Ortiz, M. and Lesa, G. and Scobie, N. and Gounaris, I. and Weiner, S.L. and Weigel, B. and Unger, T.J. and Stewart, E. and Smith, M. and Slotkin, E.K. and Reaman, G. and Pappo, A. and Nysom, K. and Norga, K. and McDonough, J. and Marshall, L.V. and Ludwinski, D. and Ligas, F. and Karres, D. and Kool, M. and Horner, T.J. and Henssen, A. and Heenen, D. and Hawkins, D.S. and Gore, L. and Bender, J.G. and Galluzzo, S. and Fox, E. and de Rojas, T. and Davies, B.R. and Chakrabarti, J. and Carmichael, J. and Bradford, D. and Blanc, P. and Bernardi, R. and Benchetrit, S. and Akindele, K. and Vassal, G.
European Journal of Cancer 190 : 112950. September 2023

Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours.
Schubert, N.A. and Chen, C.Y. and Rodríguez, A. and Koster, J. and Dowless, M. and Pfister, S.M. and Shields, D.J. and Stancato, L.F. and Vassal, G. and Caron, H.N. and van den Boogaard, M.L. and Henssen, A.G. and Molenaar, J.J.
European Journal of Cancer 170 : 196-208. July 2022

Accelerating drug development for neuroblastoma: summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
Moreno, L. and Barone, G. and DuBois, S.G. and Molenaar, J. and Fischer, M. and Schulte, J. and Eggert, A. and Schleiermacher, G. and Speleman, F. and Chesler, L. and Geoerger, B. and Hogarty, M.D. and Irwin, M.S. and Bird, N. and Blanchard, G.B. and Buckland, S. and Caron, H. and Davis, S. and De Wilde, B. and Deubzer, H.E. and Dolman, E. and Eilers, M. and George, R.E. and George, S. and Jaroslav, Š. and Maris, J.M. and Marshall, L. and Merchant, M. and Mortimer, P. and Owens, C. and Philpott, A. and Poon, E. and Shay, J.W. and Tonelli, R. and Valteau-Couanet, D. and Vassal, G. and Park, J.R. and Pearson, A.D.J.
European Journal of Cancer 136 : 52-68. September 2020

Sentinel node biopsy in gastrointestinal-tract cancer.
Schlag, P.M. and Bembenek, A. and Schulze, T.
European Journal of Cancer 40 (14): 2022-2032. September 2004

Chemotherapy in alveolar soft part sarcomas: What do we know?
Reichardt, P. and Lindner, T. and Pink, D. and Thuss-Patience, P.C. and Kretzschmar, A. and Doerken, B.
European Journal of Cancer 39 (11): 1511-1516. 1 July 2003

Palliative endoscopic therapy of rectal carcinoma.
Dohmoto, M. and Huenerbein, M. and Schlag, P.M.
European Journal of Cancer 32 (1): 25-29. 1 January 1996


Soft tissue sarcoma of high grade - a primary systemic disease?
Hohenberger, P.
European Journal of Cancer 36 : 688-690. 1 April 2000

Immune ageing and cancer.
Hartwig, M.
European Journal of Cancer 28A : 1939-1940. 1 January 1992

This list was generated on Tue May 28 02:36:50 2024 CEST.
Open Access
MDC Library